8-KThe WireRoutine
Bylaw Amendment
Filed Nov 5, 2020 · 5y ago · Accession 0001193125-20-286850
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Atea Pharmaceuticals, Inc.
- Ticker
- AVIR
- CIK
- 1593899
- Form type
- 8-K
- Filing date
- Nov 5, 2020
- Report date
- Nov 3, 2020
- Document
- d97355d8k.htm
- Size
- 268 KB